Results 151 to 160 of about 6,130,215 (205)
Some of the next articles are maybe not open access.
New management approaches for gastroparesis
Nature Clinical Practice Gastroenterology & Hepatology, 2005Management of patients with gastroparesis is challenging. Although the syndrome has multiple causes and knowledge of the pathophysiology and natural history is far from complete, a number of common management principles can be applied. The relatively poor correlation between upper-gastrointestinal symptoms and disordered gastric emptying represents a ...
Rayner, C., Horowitz, M.
openaire +3 more sources
Anticoagulation Management: A New Approach
Disease Management, 2006Anticoagulation therapy has been identified as an area in which new approaches to treatment and monitoring may allow for significant improvements in healthcare quality and costs. We evaluated the potential benefits of a new approach to anticoagulation therapy, utilizing decision support software, point-of-service testing, and workflow redesign.
Mark, Wurster, Trisha, Doran
openaire +2 more sources
New Approaches to Pain Management
Dental Clinics of North America, 2020Opioid addiction has reached epidemic proportions in the United States and it is thought that the problem started with the prescription for legal pain medications by health care professionals, particularly for treating patients who had undergone surgery.
openaire +2 more sources
Promising New Approaches to the Management of Obesity
Drugs, 2000The pathophysiology of obesity is complex with many different pathways involved. A better understanding of these weight-regulating mechanisms has lead to the identification of new targets for anti-obesity agents. Most attention has been given to the centrally acting neuropeptides regulating food intake.
Mertens, I., Van Gaal, Luc
openaire +3 more sources
New Approaches to Management of Multiple Myeloma
Current Treatment Options in Oncology, 2014Multiple myeloma is still an incurable disease with pattern of regression and remission followed by multiple relapses raising from the residual myeloma cells surviving even in the patients who achieve complete clinical response to treatment. New antimyeloma drugs such as thalidomide, lenalidomide, and bortezomib have dramatically changed treatment ...
Genadieva Stavric, S +2 more
openaire +3 more sources
New approaches to the management of fibroids
Current Opinion in Obstetrics and Gynecology, 1991It is clear that gonadotropin-releasing hormone agonists have potential as a new therapeutic approach in the treatment of fibroids. They are effective in decreasing the size of most fibroids but, on ceasing treatment, regrowth does occur. Because of their effect on calcium homeostasis, long-term unopposed use of these agonists is not recommended ...
openaire +2 more sources
NEW APPROACHES TO THE MANAGEMENT OF FIBROIDS
Obstetrics and Gynecology Clinics of North America, 2000New and innovative treatments are available for the control of uterine leiomyomata, each with advantages and disadvantages. Most of these techniques have few data to support their use; they are generally poorly studied, with brief follow-up. Not much is known regarding risks, costs, and comparative value.
openaire +2 more sources
New Approaches to the Management of COPD
Chest, 2000Airflow limitation in COPD is a result partially of bronchospasm, but it is also caused by a reduction in airway caliber, the number of small airways, airway collapse because of loss of connective tissue support, excess mucus in the airways, and edema of the airway wall.
openaire +2 more sources
New approaches for managing antiphospholipid syndrome
Nature Reviews Rheumatology, 2009Antiphospholipid antibodies (aPL) are a family of autoantibodies directed against phospholipid-binding plasma proteins, most commonly beta(2)-glycoprotein-I. Primary thrombosis prevention in persistently aPL-positive individuals requires a risk-stratified approach; elimination of reversible thrombosis risk factors and aggressive prophylaxis during high-
Doruk, Erkan, Michael D, Lockshin
openaire +2 more sources
Ezetimibe – a new approach in hypercholesterolemia management
Pharmacological Reports, 2011Ezetimibe is the first agent used in hypercholesterolemia treatment known to lower intestinal cholesterol uptake that is able to inhibit NPC1L1 transport proteins in the brush boarder of enterocytes and macrophages. Furthermore, it demonstrates anti-inflammatory and immunomodulatory properties and influences the expression of certain antigens. The drug
Dariusz, Suchy +3 more
openaire +2 more sources